Related references
Note: Only part of the references are listed.Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection
Kazumoto Murata et al.
HEPATOLOGY (2020)
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Kazumoto Murata et al.
GUT (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma A Randomized Controlled Trial
Gang Huang et al.
ANNALS OF SURGERY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load
Gang Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
Jianhua Yin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
Maurizia R. Brunetto et al.
JOURNAL OF HEPATOLOGY (2013)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
J. S. -W. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie et al.
GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Risk of recurrence in hepatitis B-related hepatocellular carcinoma: Impact of viral load in late recurrence
Yujin Hoshida
JOURNAL OF HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Donald Poon et al.
LANCET ONCOLOGY (2009)
Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection
Ivan F. N. Hung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
YF Liaw et al.
LIVER INTERNATIONAL (2005)
Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice
L Wang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2003)
Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis
Z von Marschall et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential
L Wang et al.
HEPATOLOGY (2000)